Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Mangoceuticals (NASDAQ:MGRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings.
Earnings and Valuation
This table compares Cryo-Cell International and Mangoceuticals’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Cryo-Cell International||$30.34 million||1.25||$2.77 million||$0.32||14.33|
Cryo-Cell International has higher revenue and earnings than Mangoceuticals.
|Net Margins||Return on Equity||Return on Assets|
Insider & Institutional Ownership
8.2% of Cryo-Cell International shares are held by institutional investors. 33.8% of Cryo-Cell International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This is a summary of current recommendations for Cryo-Cell International and Mangoceuticals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Cryo-Cell International presently has a consensus price target of $12.00, indicating a potential upside of 161.72%. Given Cryo-Cell International’s higher possible upside, analysts clearly believe Cryo-Cell International is more favorable than Mangoceuticals.
Cryo-Cell International beats Mangoceuticals on 7 of the 8 factors compared between the two stocks.
About Cryo-Cell International
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
Mangoceuticals Inc. is involved in developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded `Mango`. Mangoceuticals Inc. is based in DALLAS, TX.
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.